Employees: 01 (2023.0)Legal category: Société à responsabilité limitée (sans autre indication)Size: PMECreation date: 1996-06-05 (29 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: SAINT AULAYE-PUYMANGOU (24410), Dordogne
PHARMACIE DES REMPARTS : revenue, balance sheet and financial ratios
PHARMACIE DES REMPARTS is a French company
founded 29 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in SAINT AULAYE-PUYMANGOU (24410),
this company of category PME
shows in 2022 a revenue of 1.7 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DES REMPARTS (SIREN 407624543)
Indicator
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
N/C
1 674 400 €
1 819 807 €
1 576 435 €
1 640 797 €
N/C
1 785 892 €
1 775 054 €
Net income
27 707 €
61 470 €
4 389 €
32 279 €
-44 858 €
50 056 €
58 597 €
85 947 €
15 973 €
EBITDA
N/C
N/C
35 694 €
55 823 €
56 471 €
117 197 €
N/C
138 826 €
82 098 €
Net margin
N/C
N/C
0.3%
1.8%
-2.8%
3.1%
N/C
4.8%
0.9%
Revenue and income statement
In 2024, PHARMACIE DES REMPARTS generates positive net income of 28 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 16 k€ -> 28 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
27 707 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 127%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 40%. The balance between equity and debt is satisfactory.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
126.791%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
39.663%
Solvency indicators evolution PHARMACIE DES REMPARTS
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Debt ratio
132.593
96.972
86.208
73.329
242.869
210.94
190.428
150.321
126.791
Financial autonomy
38.154
44.201
48.22
51.108
25.759
28.299
29.59
36.585
39.663
Repayment capacity
19.297
6.347
None
8.269
-29.783
21.578
39.51
None
None
Cash flow / Revenue
2.382%
6.127%
None%
4.32%
-2.103%
2.3%
1.232%
None%
None%
Sector positioning
Debt ratio
126.792024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Average-7 pts over 3 years
In 2024, the debt ratio of PHARMACIE DES REMPARTS (126.79) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
39.66%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Average+11 pts over 3 years
In 2024, the financial autonomy of PHARMACIE DES REMPARTS (39.7%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Repayment capacity
39.51 years2022
2022
Q1: 1.29 years
Med: 3.55 years
Q3: 6.63 years
Watch
In 2022, the repayment capacity of PHARMACIE DES REMPARTS (39.51) ranks in the top 25% of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A long duration may signal heavy debt relative to repayment capacity.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 79.44. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
79.435
Liquidity indicators evolution PHARMACIE DES REMPARTS
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
133.747
131.813
148.597
157.822
156.762
140.4
106.976
111.813
79.435
Interest coverage
33.499
18.507
None
24.722
27.256
25.979
40.306
None
None
Sector positioning
Liquidity ratio
79.442024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Watch
In 2024, the liquidity ratio of PHARMACIE DES REMPARTS (79.44) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Interest coverage
40.31x2022
2022
Q1: 0.74x
Med: 2.5x
Q3: 5.15x
Excellent
In 2022, the interest coverage of PHARMACIE DES REMPARTS (40.3x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE DES REMPARTS
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Operating WCR
243 076 €
235 523 €
0 €
286 434 €
215 577 €
233 754 €
177 687 €
0 €
0 €
Inventory turnover (days)
25
25
0
30
30
32
27
0
0
Customer payment term (days)
9
10
0
12
15
11
12
191
0
Supplier payment term (days)
40
47
0
46
37
32
37
574
0
Positioning of PHARMACIE DES REMPARTS in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE DES REMPARTS is estimated at
386 810 €
(range 269 368€ - 578 690€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
269k€386k€578k€
386 810 €Range: 269 368€ - 578 690€
NAF 5 année 2024
Valuation method used
Net Income Multiple
27 707 €
×
14.0x
=386 810 €
Range: 269 369€ - 578 690€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DES REMPARTS with other companies in the same sector:
Frequently asked questions about PHARMACIE DES REMPARTS
What is the revenue of PHARMACIE DES REMPARTS ?
The revenue of PHARMACIE DES REMPARTS in 2022 is 1.7 M€.
Is PHARMACIE DES REMPARTS profitable?
Yes, PHARMACIE DES REMPARTS generated a net profit of 28 k€ in 2024.
Where is the headquarters of PHARMACIE DES REMPARTS ?
The headquarters of PHARMACIE DES REMPARTS is located in SAINT AULAYE-PUYMANGOU (24410), in the department Dordogne.
Where to find the tax return of PHARMACIE DES REMPARTS ?
The tax return of PHARMACIE DES REMPARTS is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DES REMPARTS operate?
PHARMACIE DES REMPARTS operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart